Antibodies
Showing 31–45 of 397 results
-
Atibuclimab (anti-CD14)
$67.37 – $1,357.97 -
Avdoralimab (anti-C5AR1)
$148.37 – $3,023.87 -
Avizakimab (anti-IL-21)
$148.37 – $3,023.87 -
bamlanivimab
$3,603.02 – $6,303.02 -
Bapineuzumab (anti-APP)
$67.37 -
barzolvolimab
$3,603.02 – $6,303.02 -
Basiliximab (anti-IL-2Ra)
$134.87 – $2,888.87 -
Bavituximab (anti-Phosphatidylserine)
$148.37 – $3,091.37 -
bebtelovimab
$3,603.02 – $6,303.02 -
Begelomab (anti-DPP4)
$148.37 – $3,023.87 -
Belantamab (anti-TNFRSF17)
$94.37 – $1,333.67 -
belantamab mafodotin
$3,603.02 – $6,303.02 -
belimumab
$3,603.02 – $6,303.02 -
Bemarituzumab (anti-FGFR2)
$67.37 – $1,333.67 -
Benralizumab (anti-IL-5Ra)
$188.87 – $5,345.87